Elijah Ejun Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elijah Ejun Huang has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Stuart Barry Goodman
Stanford University Medical Center
3 shared publications Fan Yang
Department of Orthopaedic Surgery, Stanford University School of Medicine, California, USA
2 shared publications- Masahiro Maruyama
Department of Orthopaedic Surgery Stanford University School of Medicine Stanford California USA
2 shared publications - Ning Zhang
Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong Special Administrative Region of China; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region of China
2 shared publications Qi Gao
Department of Orthopaedic Surgery, Stanford University School of Medicine, California, USA
2 shared publicationsBrice Gaudillière
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA, USA
1 shared publication
Latest Publications
- Open Access
- 10 September 2025
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 55, 121-131
Single-cell RNA sequencing reveals early cell dynamics of MSC-based therapy in long bone critical-size defects in mice
- 10 September 2025
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 55, 121-131
Open AccessSingle-cell RNA sequencing reveals early cell dynamics of MSC-based therapy in long bone critical-size defects in mice
- Open Access
- 4 August 2022
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 36, 64-74
Differential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect
- 4 August 2022
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 36, 64-74
Open AccessDifferential dynamics of bone graft transplantation and mesenchymal stem cell therapy during bone defect healing in a murine critical size defect
- Open Access
- 11 April 2022
- Published by MDPI AG in Bioengineering
- Vol. 9 (4) , 171
Novel Techniques and Future Perspective for Investigating Critical-Size Bone Defects
A critical-size bone defect is a challenging clinical problem in which a gap between bone ends will not heal and will become a nonunion. The current treatment is to harvest and transplant an autologous bone graft to facilitate bone bridging. To develop less invasive but equally effective treatment options, one needs to first have a comprehensive understanding of the bone healing process. Therefore, it is imperative to leverage the most advanced technologies to elucidate the fundamental concepts of the bone healing process and develop innovative therapeutic strategies to bridge the nonunion gap. In this review, we first discuss the current animal models to study critical-size bone defects. Then, we focus on four novel analytic techniques and discuss their strengths and limitations. These four technologies are mass cytometry (CyTOF) for enhanced cellular analysis, imaging mass cytometry (IMC) for enhanced tissue special imaging, single-cell RNA sequencing (scRNA-seq) for detailed transcriptome analysis, and Luminex assays for comprehensive protein secretome analysis. With this new understanding of the healing of critical-size bone defects, novel methods of diagnosis and treatment will emerge.
- 11 April 2022
- Published by MDPI AG in Bioengineering
- Vol. 9 (4) , 171
Open AccessNovel Techniques and Future Perspective for Investigating Critical-Size Bone Defects
A critical-size bone defect is a challenging clinical problem in which a gap between bone ends will not heal and will become a nonunion. The current treatment is to harvest and transplant an autologous bone graft to facilitate bone bridging. To develop less invasive but equally effective treatment options, one needs to first have a comprehensive understanding of the bone healing process. Therefore, it is imperative to leverage the most advanced technologies to elucidate the fundamental concepts of the bone healing process and develop innovative therapeutic strategies to bridge the nonunion gap. In this review, we first discuss the current animal models to study critical-size bone defects. Then, we focus on four novel analytic techniques and discuss their strengths and limitations. These four technologies are mass cytometry (CyTOF) for enhanced cellular analysis, imaging mass cytometry (IMC) for enhanced tissue special imaging, single-cell RNA sequencing (scRNA-seq) for detailed transcriptome analysis, and Luminex assays for comprehensive protein secretome analysis. With this new understanding of the healing of critical-size bone defects, novel methods of diagnosis and treatment will emerge.